ClinicalTrials.Veeva

Menu

Epidemiological Description of the Kaposi's Disease in France's Southeast (KAPOSI-1)

D

Direction Centrale du Service de Santé des Armées

Status

Unknown

Conditions

Kaposi's Disease

Study type

Observational

Funder types

Other

Identifiers

NCT03662828
KAPOSI-1

Details and patient eligibility

About

The purpose of this study is to evaluate the prevalence of the Kaposi's disease in France's southeast on 10 years (from 2007 to 2017)

Full description

Kaposi's disease is a multifocal disease with cutaneous expression in more than 95% of cases.

There are 4 forms : Mediterranean, Endemic (Sub-Saharan Africa), iatrogenic and epidemic (HIV) The physiological hypotheses to explain the disease are not clear. A proliferation of immunity cells in blood vessels and also an undetermined role of the human herpes virus 8 (HHV-8) could be involved.

The treatment is complex and not standardized. There are a lot of different treatments.

The purpose of this study is to evaluate the prevalence and described the characteristics and the treatment of the Kaposi's disease in the France's southeast on 10 years, from 2007 to 2017.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed patients with a Kaposi's disease by biopsy from January 2007 to December 2017

Exclusion criteria

  • Opposition to the use of personal data

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems